董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Stephen A. Odland | 男 | Director | 59 | 19.50万美元 | 未持股 | 2017-11-02 |
| Bernard C. Bailey | 男 | Director | 64 | 26.13万美元 | 未持股 | 2017-11-02 |
| James J. Judge | 男 | Director | 61 | 20.25万美元 | 未持股 | 2017-11-02 |
| Michael T. Modic | 男 | Director | 67 | 18.63万美元 | 未持股 | 2017-11-02 |
| Fred B. Parks | 男 | Director,President and Chief Executive Officer | 70 | 3.00万美元 | 未持股 | 2017-11-02 |
| Joseph E. Whitters | 男 | Director | 59 | 未披露 | 未持股 | 2017-11-02 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Michael J. Bourque | 男 | Senior Vice President, Chief Financial Officer and Treasurer | 54 | 40.40万美元 | 未持股 | 2017-11-02 |
| Brooks West | 男 | Senior Vice President and General Manager | 47 | 未披露 | 未持股 | 2017-11-02 |
| Fred B. Parks | 男 | Director,President and Chief Executive Officer | 70 | 3.00万美元 | 未持股 | 2017-11-02 |
| John J. Fry | 男 | Senior Vice President, General Counsel and Secretary | 56 | 96.90万美元 | 未持股 | 2017-11-02 |
| James P. Ryan | 男 | Senior Vice President and General Manager | 47 | 82.33万美元 | 未持股 | 2017-11-02 |
| Mervat Faltas | 女 | Senior Vice President and General Manager | 65 | 79.59万美元 | 未持股 | 2017-11-02 |
董事简历
中英对照 | 中文 | 英文- Stephen A. Odland
-
Stephen A. Odland，一直担任the Committee for Economic Development（一个非营利组织，公共政策组织）的总裁兼首席执行官（2013年以来）。2011年至2012年，他曾担任林恩大学商学院（the graduate school of business at Lynn University）、Florida Atlantic University的副教授。他曾担任Office Depot, Inc.（一个办公室商品零售商）的主席兼首席执行官（2005年至2010年）。从2001年到2005年，他担任AutoZone, Inc（一个汽车配件零售商）的主席兼首席执行官。此前，他曾担任Ahold U.S.A.（国际食品零售商）的执行官（从1998年到2000年），以及Sara Lee Bakery的食品服务部门的总裁（1997年至1998年）。他曾任职The Quaker Oats Company（从1981年到1996年）。
Stephen A. Odland has been President and Chief Executive Officer of the Committee for Economic Development, a non-profit, public policy organization, since 2013. From 2011 to 2012 he was an Adjunct Professor in the graduate schools of business at Lynn University and at Florida Atlantic University. Mr. Odland served as Chairman and Chief Executive Officer of Office Depot, Inc., an office merchandise retailer, from 2005 until 2010. From 2001 to 2005 he was Chairman and Chief Executive Officer of AutoZone, Inc., an auto parts retailer. Prior to that, he served as an executive with Ahold U.S.A., an international food retailer, from 1998 to 2000 and as President of the Foodservice Division of Sara Lee Bakery from 1997 to 1998. He was employed by The Quaker Oats Company from 1981 to 1996.Mr. Odland serves on the board of General Mills, Inc., a leading global manufacturer and marketer of branded and unbranded foods sold through retail and business-to-business channels worldwide, where he is a member of the Corporate Governance and Compensation Committees. He also serves as a trustee of the Conference Board, a global, independent business membership and research association working to provide the world's leading organizations with the practical knowledge they need to improve their performance and better serve society. Mr. Odland is also a contributor to CNBC, and has served as a Senior Advisor to Peter J. Solomon Company, since 2016. - Stephen A. Odland，一直担任the Committee for Economic Development（一个非营利组织，公共政策组织）的总裁兼首席执行官（2013年以来）。2011年至2012年，他曾担任林恩大学商学院（the graduate school of business at Lynn University）、Florida Atlantic University的副教授。他曾担任Office Depot, Inc.（一个办公室商品零售商）的主席兼首席执行官（2005年至2010年）。从2001年到2005年，他担任AutoZone, Inc（一个汽车配件零售商）的主席兼首席执行官。此前，他曾担任Ahold U.S.A.（国际食品零售商）的执行官（从1998年到2000年），以及Sara Lee Bakery的食品服务部门的总裁（1997年至1998年）。他曾任职The Quaker Oats Company（从1981年到1996年）。
- Stephen A. Odland has been President and Chief Executive Officer of the Committee for Economic Development, a non-profit, public policy organization, since 2013. From 2011 to 2012 he was an Adjunct Professor in the graduate schools of business at Lynn University and at Florida Atlantic University. Mr. Odland served as Chairman and Chief Executive Officer of Office Depot, Inc., an office merchandise retailer, from 2005 until 2010. From 2001 to 2005 he was Chairman and Chief Executive Officer of AutoZone, Inc., an auto parts retailer. Prior to that, he served as an executive with Ahold U.S.A., an international food retailer, from 1998 to 2000 and as President of the Foodservice Division of Sara Lee Bakery from 1997 to 1998. He was employed by The Quaker Oats Company from 1981 to 1996.Mr. Odland serves on the board of General Mills, Inc., a leading global manufacturer and marketer of branded and unbranded foods sold through retail and business-to-business channels worldwide, where he is a member of the Corporate Governance and Compensation Committees. He also serves as a trustee of the Conference Board, a global, independent business membership and research association working to provide the world's leading organizations with the practical knowledge they need to improve their performance and better serve society. Mr. Odland is also a contributor to CNBC, and has served as a Senior Advisor to Peter J. Solomon Company, since 2016.
- Bernard C. Bailey
-
Bernard C. Bailey，2012年以来他一直是Authentix公司的首席执行官和董事会主席。从2006年至2012年他担任Paraquis解决方案有限责任公司总裁。从2002年到2006年他是L-1 Identity Solutions公司（为政府，执法机构和公司提供先进的技术身份解决方案的开发商）的总裁兼首席执行官，此前为Viisage科技公司。他曾担任艺术科技集团（电子商务软件解决方案的开发商和销售商）的首席营运官，在IBM公司工作17年并担任多个行政职位。他亦担任Telos公司的董事。在过去的五年中，他曾担任以下上市公司的董事局成员：LASERCARD公司，EF Johnson Technologies公司，Spectrum Control公司，IDENTIVE集团，和空白点解决方案公司。他有资格担任公司董事，是由于他在安全技术行业拥有丰富经验，并服务于公共和私营部门的客户。他还带来了三十年的科技行业高管经验，包括作为公共公司的首席执行官，以及丰富的董事会经验，和公司治理的深刻理解。他最近获得了凯斯西储大学管理博士学位，其博士论文侧重于公司治理。他曾担任过特拉华州衡平法院的专家证人，曾任关于企业管治会议的发言人，并已在同行评审的学术期刊上发表了关于公司治理的文章。他持有美国公司董事学院的一个硕士董事专业认证，并为全国公司董事协会的成员。
Bernard C. Bailey, President of Paraquis Solutions, a private consulting company focused on corporate governance and strategy January 2020 - present. During the period September 2018 to December 2019 he served as President of the Committee for Economic Development, a business-led, nonpartisan economic think tank. Served as Chairman and CEO of Authentix, a private equity-backed global enterprise focused on anticounterfeiting and brand protection practices, from 2012 to 2018. Since its sale by the Carlyle Group to Blue Water Energy, he has continued to serve as Chairman of the Board of Authentix since September 2018. Prior to that, he ran his own consulting company, Paraquis Solutions, LLC. Dr. Bailey also served as President and CEO of Viisage Technology, Inc. Ph.D. in Management from Case Western Reserve University where his dissertation focused on corporate governance; MBA from The George Washington University School of Business as well as degrees in engineering and systems management from the University of California, Berkeley, University of Southern California, and the United States Naval Academy. - Bernard C. Bailey，2012年以来他一直是Authentix公司的首席执行官和董事会主席。从2006年至2012年他担任Paraquis解决方案有限责任公司总裁。从2002年到2006年他是L-1 Identity Solutions公司（为政府，执法机构和公司提供先进的技术身份解决方案的开发商）的总裁兼首席执行官，此前为Viisage科技公司。他曾担任艺术科技集团（电子商务软件解决方案的开发商和销售商）的首席营运官，在IBM公司工作17年并担任多个行政职位。他亦担任Telos公司的董事。在过去的五年中，他曾担任以下上市公司的董事局成员：LASERCARD公司，EF Johnson Technologies公司，Spectrum Control公司，IDENTIVE集团，和空白点解决方案公司。他有资格担任公司董事，是由于他在安全技术行业拥有丰富经验，并服务于公共和私营部门的客户。他还带来了三十年的科技行业高管经验，包括作为公共公司的首席执行官，以及丰富的董事会经验，和公司治理的深刻理解。他最近获得了凯斯西储大学管理博士学位，其博士论文侧重于公司治理。他曾担任过特拉华州衡平法院的专家证人，曾任关于企业管治会议的发言人，并已在同行评审的学术期刊上发表了关于公司治理的文章。他持有美国公司董事学院的一个硕士董事专业认证，并为全国公司董事协会的成员。
- Bernard C. Bailey, President of Paraquis Solutions, a private consulting company focused on corporate governance and strategy January 2020 - present. During the period September 2018 to December 2019 he served as President of the Committee for Economic Development, a business-led, nonpartisan economic think tank. Served as Chairman and CEO of Authentix, a private equity-backed global enterprise focused on anticounterfeiting and brand protection practices, from 2012 to 2018. Since its sale by the Carlyle Group to Blue Water Energy, he has continued to serve as Chairman of the Board of Authentix since September 2018. Prior to that, he ran his own consulting company, Paraquis Solutions, LLC. Dr. Bailey also served as President and CEO of Viisage Technology, Inc. Ph.D. in Management from Case Western Reserve University where his dissertation focused on corporate governance; MBA from The George Washington University School of Business as well as degrees in engineering and systems management from the University of California, Berkeley, University of Southern California, and the United States Naval Academy.
- James J. Judge
-
James J. Judge， 自2012年4月10日起担任东北通用、 CL&P, NSTAR电气， NSTAR 天然气， PSNH, WMECO， 扬基气体和努斯科执行副总裁兼首席财务官。自2012年4月10日起担任 CL&P, PSNH, WMECO， 扬基气体和努斯科董事； 自1999年9月27日起担任NSTAR电气， NSTAR 天然气董事；从1999年到2012年4月担任 NSTAR、 NSTAR电气和 NSTAR 天然气高级副总裁兼首席财务官。自2012年4月10日起担任东北通用基金风险官和董事。自1995年12月12日成为NSTAR 基金信托人。
James J. Judge has served as Executive Chairman of the Board of Eversource Energy since May 5 2021. He served as President and Chief Executive Officer from May 2016 to May 2017 and as Chairman, President and Chief Executive Officer of Eversource Energy and its principal subsidiaries from 2017 to May 2021. Previously, Mr. Judge was Executive Vice President and Chief Financial Officer of Eversource Energy and its principal subsidiaries from April 2012 until May 2016. Mr. Judge served as a director of Analogic Corporation beginning in 2005 and as chairman of its audit committee until Analogic Corporation's sale in 2018. He serves on the Board of Directors of the Edison Electric Institute, and the Massachusetts Competitive Partnership. He has also served on the Board of Directors of the United Way of Massachusetts Bay and Merrimack Valley and the John F. Kennedy Library Foundation. Mr. Judge received both a B.S. degree magna cum laude and an M.B.A. degree magna cum laude from Babson College. - James J. Judge， 自2012年4月10日起担任东北通用、 CL&P, NSTAR电气， NSTAR 天然气， PSNH, WMECO， 扬基气体和努斯科执行副总裁兼首席财务官。自2012年4月10日起担任 CL&P, PSNH, WMECO， 扬基气体和努斯科董事； 自1999年9月27日起担任NSTAR电气， NSTAR 天然气董事；从1999年到2012年4月担任 NSTAR、 NSTAR电气和 NSTAR 天然气高级副总裁兼首席财务官。自2012年4月10日起担任东北通用基金风险官和董事。自1995年12月12日成为NSTAR 基金信托人。
- James J. Judge has served as Executive Chairman of the Board of Eversource Energy since May 5 2021. He served as President and Chief Executive Officer from May 2016 to May 2017 and as Chairman, President and Chief Executive Officer of Eversource Energy and its principal subsidiaries from 2017 to May 2021. Previously, Mr. Judge was Executive Vice President and Chief Financial Officer of Eversource Energy and its principal subsidiaries from April 2012 until May 2016. Mr. Judge served as a director of Analogic Corporation beginning in 2005 and as chairman of its audit committee until Analogic Corporation's sale in 2018. He serves on the Board of Directors of the Edison Electric Institute, and the Massachusetts Competitive Partnership. He has also served on the Board of Directors of the United Way of Massachusetts Bay and Merrimack Valley and the John F. Kennedy Library Foundation. Mr. Judge received both a B.S. degree magna cum laude and an M.B.A. degree magna cum laude from Babson College.
- Michael T. Modic
-
Michael T. Modic，自2006年他一直是在克利夫兰诊所基金会的神经学研究所的。自2005年以来，他也是在凯斯西储大学的克利夫兰诊所勒纳医学院的放射学教授。从1989年到2005年，他是放射科在克利夫兰诊所的所长。从2000年至2005年他也是克利夫兰诊所基金会理事会的一员。他曾任俄亥俄州立大学的医学和公共卫生学院放射学教授。他曾服务于美国神经放射学，医学磁共振和磁共振成像杂志的放射学的编委。他的资历，包括他在医疗保健领域拥有丰富的经验，是作为一个国际认可的医疗机构的领导者和执业医师，这两者也提供观点的多样性。他为董事会提供医疗保健行业的有价值的见解，包括医疗政策的趋势以及有关医疗设备和服务的机会。
Michael T. Modic is the Chief Clinical Transformation Officer for the Cleveland Clinic Health System, a position he has held since January 2015. He has chaired the Capital Review Committee of the Cleveland Clinic since 1995. He previously served in a number of key roles at the Cleveland Clinic, including the Chairman of the Neurological Institute from 2006 through 2015 Chairman of the Division of Radiology from 1989 through 2005 and as a member of the Board of Governors from 2000 to 2005. He is currently a Professor of Radiology, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He was previously a Professor of Radiology at The Ohio State University College of Medicine and Public Health and Professor of Radiology and Neurosurgery at Case Western Reserve University School of Medicine. Dr. Modic has served on the editorial boards of the journals Radiology, American Journal of Neuroradiology, Magnetic Resonance in Medicine, and Magnetic Resonance Imaging.Dr. Modic’s qualifications include his extensive experience in the healthcare field, both as a leader of an internationally recognized healthcare institution and as a practicing physician, both of which provide diversity of viewpoint. Dr. Modic provides our board with valuable insight into the healthcare industry, including trends in healthcare policy, reimbursement and opportunities relating to healthcare equipment and services. - Michael T. Modic，自2006年他一直是在克利夫兰诊所基金会的神经学研究所的。自2005年以来，他也是在凯斯西储大学的克利夫兰诊所勒纳医学院的放射学教授。从1989年到2005年，他是放射科在克利夫兰诊所的所长。从2000年至2005年他也是克利夫兰诊所基金会理事会的一员。他曾任俄亥俄州立大学的医学和公共卫生学院放射学教授。他曾服务于美国神经放射学，医学磁共振和磁共振成像杂志的放射学的编委。他的资历，包括他在医疗保健领域拥有丰富的经验，是作为一个国际认可的医疗机构的领导者和执业医师，这两者也提供观点的多样性。他为董事会提供医疗保健行业的有价值的见解，包括医疗政策的趋势以及有关医疗设备和服务的机会。
- Michael T. Modic is the Chief Clinical Transformation Officer for the Cleveland Clinic Health System, a position he has held since January 2015. He has chaired the Capital Review Committee of the Cleveland Clinic since 1995. He previously served in a number of key roles at the Cleveland Clinic, including the Chairman of the Neurological Institute from 2006 through 2015 Chairman of the Division of Radiology from 1989 through 2005 and as a member of the Board of Governors from 2000 to 2005. He is currently a Professor of Radiology, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He was previously a Professor of Radiology at The Ohio State University College of Medicine and Public Health and Professor of Radiology and Neurosurgery at Case Western Reserve University School of Medicine. Dr. Modic has served on the editorial boards of the journals Radiology, American Journal of Neuroradiology, Magnetic Resonance in Medicine, and Magnetic Resonance Imaging.Dr. Modic’s qualifications include his extensive experience in the healthcare field, both as a leader of an internationally recognized healthcare institution and as a practicing physician, both of which provide diversity of viewpoint. Dr. Modic provides our board with valuable insight into the healthcare industry, including trends in healthcare policy, reimbursement and opportunities relating to healthcare equipment and services.
- Fred B. Parks
-
Fred B. Parks，他担任NDS外科成像公司（先进的医疗可视化技术提供商）的行政总裁及董事从2011年至2013。他曾担任Urologix的董事会主席及行政总裁从2003至2008年。在加入Urologix前，他担任马可尼医疗系统（医疗成像设备的多模态供应商）的总裁兼首席执行官，后来该公司被皇家飞利浦电子收购，使其融入飞利浦医疗业务。此前，他担任圣犹达医疗用品公司（一家医疗设备公司，专注于植入式心血管产品）的总裁，首席营运官及董事会成员，并担任EG＆G公司（现在为珀金埃尔默，一家多元化的科技公司）总裁，首席营运官及董事会成员。除了他过去服务于NDS，Urologix，EG＆G，和圣犹达医疗的董事会，他还服务于稳态成像有限责任公司（一家私人持有的磁共振成像技术开发商）的董事会从2010年到2011。他的资历包括他的丰富工作经验，为一些科技公司的高级管理人员和董事会成员，特别是在医疗设备和医疗成像等行业。
Fred B. Parks has been our President and Chief Executive Officer since October 31 2016. Dr. Parks was the Executive Chairman and Chief Executive Officer of Enovate Medical, from 2015 to October 2016. Dr. Parks served as Chief Executive Officer and Director of NDS Surgical Imaging, Inc., a provider of advanced medical visualization technology, from 2011 to 2013 and was Chairman of the Board and Chief Executive Officer of Urologix, Inc. from 2003 to 2008. Prior to joining Urologix, Dr. Parks served as President and Chief Executive Officer of Marconi Medical Systems, a multi-modality supplier of medical imaging equipment, and following its acquisition by Royal Philips Electronics, led its integration into the Philips medical business. Previously, Dr. Parks held positions as President, Chief Operating Officer, and board member of St. Jude Medical, Inc., a medical device company focusing on implantable cardiovascular products, and as President, Chief Operating Officer, and board member of EG&G, Inc. now PerkinElmer, a diversified technology company.Dr. Parks became a Director of NuVectra Corporation, which is focused on the development and commercialization of neurostimulation technology, in March 2016. In addition to his past service on the boards of NDS, Urologix, EG&G, and St. Jude Medical, Dr. Parks served on the board of Steady State Imaging, LLC, a privately held developer of specialized magnetic resonance imaging technology, from 2010 to 2011.Dr. Parks’ qualifications include his substantial experience as a senior executive and board member for a number of technology companies, and particularly in the medical device and medical imaging industries. As President and Chief Executive Officer of Analogic, his in-depth knowledge of our Company provides our board with additional insight in areas such as strategic planning, financial and budgeting matters, engineering and product development, operations, sales and marketing, general management and other areas impacting our Company and its operations. - Fred B. Parks，他担任NDS外科成像公司（先进的医疗可视化技术提供商）的行政总裁及董事从2011年至2013。他曾担任Urologix的董事会主席及行政总裁从2003至2008年。在加入Urologix前，他担任马可尼医疗系统（医疗成像设备的多模态供应商）的总裁兼首席执行官，后来该公司被皇家飞利浦电子收购，使其融入飞利浦医疗业务。此前，他担任圣犹达医疗用品公司（一家医疗设备公司，专注于植入式心血管产品）的总裁，首席营运官及董事会成员，并担任EG＆G公司（现在为珀金埃尔默，一家多元化的科技公司）总裁，首席营运官及董事会成员。除了他过去服务于NDS，Urologix，EG＆G，和圣犹达医疗的董事会，他还服务于稳态成像有限责任公司（一家私人持有的磁共振成像技术开发商）的董事会从2010年到2011。他的资历包括他的丰富工作经验，为一些科技公司的高级管理人员和董事会成员，特别是在医疗设备和医疗成像等行业。
- Fred B. Parks has been our President and Chief Executive Officer since October 31 2016. Dr. Parks was the Executive Chairman and Chief Executive Officer of Enovate Medical, from 2015 to October 2016. Dr. Parks served as Chief Executive Officer and Director of NDS Surgical Imaging, Inc., a provider of advanced medical visualization technology, from 2011 to 2013 and was Chairman of the Board and Chief Executive Officer of Urologix, Inc. from 2003 to 2008. Prior to joining Urologix, Dr. Parks served as President and Chief Executive Officer of Marconi Medical Systems, a multi-modality supplier of medical imaging equipment, and following its acquisition by Royal Philips Electronics, led its integration into the Philips medical business. Previously, Dr. Parks held positions as President, Chief Operating Officer, and board member of St. Jude Medical, Inc., a medical device company focusing on implantable cardiovascular products, and as President, Chief Operating Officer, and board member of EG&G, Inc. now PerkinElmer, a diversified technology company.Dr. Parks became a Director of NuVectra Corporation, which is focused on the development and commercialization of neurostimulation technology, in March 2016. In addition to his past service on the boards of NDS, Urologix, EG&G, and St. Jude Medical, Dr. Parks served on the board of Steady State Imaging, LLC, a privately held developer of specialized magnetic resonance imaging technology, from 2010 to 2011.Dr. Parks’ qualifications include his substantial experience as a senior executive and board member for a number of technology companies, and particularly in the medical device and medical imaging industries. As President and Chief Executive Officer of Analogic, his in-depth knowledge of our Company provides our board with additional insight in areas such as strategic planning, financial and budgeting matters, engineering and product development, operations, sales and marketing, general management and other areas impacting our Company and its operations.
- Joseph E. Whitters
-
Joseph E. Whitters，自2018年7月起担任Accuray Incorporated董事会成员。自2005年以来，惠特斯一直担任私募股权公司Frazier Healthcare的顾问/顾问。从1986年到2005年，Whitters先生在First Health Group Corp.（一家上市的管理式医疗公司）担任各种职务，最近担任其首席财务官。此前，他还曾在1984年至1986年期间担任公开上市的医疗保健管理公司United Healthcare Corp的财务总监。在此之前，Whitters先生曾担任上市卡车运输公司Overland Express的会计和税务经理，他的公共会计职业生涯始于Peat Marwick（现毕马威）。Whitters曾在多家上市公司的董事会和审计委员会任职，其中包括全球美容设备公司Cutera, Inc.，从2019年2月至2023年6月，InfuSystem Holdings，Inc.，一家输液泵及相关产品和服务的公开交易供应商，从2012年4月至2019年5月；医疗保健和安全技术解决方案私营公司，从2017年10月至2018年6月；PRGX全球，Inc.，一家恢复审计和支出分析服务的私营供应商，从2013年2月至2021年3月；SPARK网络，一家优质在线约会网站和移动应用程序的私营运营商，2021年7月至2024年2月；以及私营空中医疗运输和空中旅游公司Air Methods公司，2016年3月至2017年4月。Whitters还曾是多家私营公司的顾问或董事会成员。Whitters先生拥有路德学院会计学学士学位。
Joseph E. Whitters has served as a member of Board since July 2018. Mr. Whitters has been an advisor/consultant to Frazier Healthcare, a private equity firm, since 2005. From 1986 to 2005, Mr. Whitters served in vario capacities with First Health Group Corp., a publicly traded managed care company, most recently as its Chief Financial Officer. He also previoly served as the Controller for United Healthcare Corp, a publicly traded health care management company, from 1984 to 1986. Prior to that, Mr. Whitters served as the Manager of Accounting and Taxation for Overland Express, a publicly traded trucking company, and he began his career in public accounting with Peat Marwick (now KPMG). Whitters has served on the boards of directors and audit committees of vario public companies, including Cutera, Inc., a global aesthetics device company, from February 2019 through June 2023; Infystem Holdings, Inc., a publicly traded provider of infion pumps and related products and services, from April 2012 through May 2019; Analogic Corporation, a private healthcare and security technology solutions company, from October 2017 through June 2018; PRGX Global, Inc., a private provider of recovery audit and spend analytics services, from February 2013 to March 2021; Spark Networks, a private operator of premium online dating sites and mobile applications, from July 2021 to February 2024; and Air Methods Corp., a private air medical transportation and air tism company, from March 2016 through April 2017. Mr. Whitters has also been an advisor or board member of several private companies. Mr. Whitters holds a B.A. in Accounting from Luther College. - Joseph E. Whitters，自2018年7月起担任Accuray Incorporated董事会成员。自2005年以来，惠特斯一直担任私募股权公司Frazier Healthcare的顾问/顾问。从1986年到2005年，Whitters先生在First Health Group Corp.（一家上市的管理式医疗公司）担任各种职务，最近担任其首席财务官。此前，他还曾在1984年至1986年期间担任公开上市的医疗保健管理公司United Healthcare Corp的财务总监。在此之前，Whitters先生曾担任上市卡车运输公司Overland Express的会计和税务经理，他的公共会计职业生涯始于Peat Marwick（现毕马威）。Whitters曾在多家上市公司的董事会和审计委员会任职，其中包括全球美容设备公司Cutera, Inc.，从2019年2月至2023年6月，InfuSystem Holdings，Inc.，一家输液泵及相关产品和服务的公开交易供应商，从2012年4月至2019年5月；医疗保健和安全技术解决方案私营公司，从2017年10月至2018年6月；PRGX全球，Inc.，一家恢复审计和支出分析服务的私营供应商，从2013年2月至2021年3月；SPARK网络，一家优质在线约会网站和移动应用程序的私营运营商，2021年7月至2024年2月；以及私营空中医疗运输和空中旅游公司Air Methods公司，2016年3月至2017年4月。Whitters还曾是多家私营公司的顾问或董事会成员。Whitters先生拥有路德学院会计学学士学位。
- Joseph E. Whitters has served as a member of Board since July 2018. Mr. Whitters has been an advisor/consultant to Frazier Healthcare, a private equity firm, since 2005. From 1986 to 2005, Mr. Whitters served in vario capacities with First Health Group Corp., a publicly traded managed care company, most recently as its Chief Financial Officer. He also previoly served as the Controller for United Healthcare Corp, a publicly traded health care management company, from 1984 to 1986. Prior to that, Mr. Whitters served as the Manager of Accounting and Taxation for Overland Express, a publicly traded trucking company, and he began his career in public accounting with Peat Marwick (now KPMG). Whitters has served on the boards of directors and audit committees of vario public companies, including Cutera, Inc., a global aesthetics device company, from February 2019 through June 2023; Infystem Holdings, Inc., a publicly traded provider of infion pumps and related products and services, from April 2012 through May 2019; Analogic Corporation, a private healthcare and security technology solutions company, from October 2017 through June 2018; PRGX Global, Inc., a private provider of recovery audit and spend analytics services, from February 2013 to March 2021; Spark Networks, a private operator of premium online dating sites and mobile applications, from July 2021 to February 2024; and Air Methods Corp., a private air medical transportation and air tism company, from March 2016 through April 2017. Mr. Whitters has also been an advisor or board member of several private companies. Mr. Whitters holds a B.A. in Accounting from Luther College.
高管简历
中英对照 | 中文 | 英文- Michael J. Bourque
Michael J. Bourque，他是我们的临时首席财务官兼财务主管（2015年4月以来）。他于2014年10月加入我们，并担任公司的副总裁兼公司总会计师。从2011年7月到2014年10月，他曾担任Axcelis Technologies公司（公开交易的全球半导体制造业产品的供应商）的副总裁兼公司总会计师。他曾担任Axcelis公司的财务顾问（从2011年4月到2011年7月）。从2002年11月到2010年10月，他曾担任多种财务会计职务，包括Charles River Laboratories公司（世界各地的领先制药、生物技术、政府和学术机构的产品和服务的公开交易供应商）的公司会计董事兼助理公司总会计师。职业生涯早期，他曾担任Ernst & Young公司的多种审计实践职务，并不断被提拔，也是注册会计师。
Michael J. Bourque is our Senior Vice President, Chief Financial Officer and Treasurer, and has served in this capacity since July 13 2017. Mr. Bourque joined us in October 2014 as Vice President and Corporate Controller. He served as the Company’s interim Chief Financial Officer from April 2015 through November 2015 before being named principal accounting officer in December 2017. From July 2011 to October 2014 Mr. Bourque served as Vice President and Corporate Controller of Axcelis Technologies, Inc. which we refer to as Axcelis, a publicly traded supplier of products for the semiconductor manufacturing industry worldwide. He served as a financial consultant to Axcelis from April 2011 to July 2011. From November 2002 through October 2010 he served in a variety of finance and accounting roles, including Director of Corporate Accounting and Assistant Corporate Controller, at Charles River Laboratories, Inc., a publicly traded provider of products and services to leading pharmaceutical, biotechnology, government and academic organizations around the world. Earlier in his career, Mr. Bourque held various positions of increasing responsibility in the audit practice at Ernst & Young, LLP and is a certified public accountant.- Michael J. Bourque，他是我们的临时首席财务官兼财务主管（2015年4月以来）。他于2014年10月加入我们，并担任公司的副总裁兼公司总会计师。从2011年7月到2014年10月，他曾担任Axcelis Technologies公司（公开交易的全球半导体制造业产品的供应商）的副总裁兼公司总会计师。他曾担任Axcelis公司的财务顾问（从2011年4月到2011年7月）。从2002年11月到2010年10月，他曾担任多种财务会计职务，包括Charles River Laboratories公司（世界各地的领先制药、生物技术、政府和学术机构的产品和服务的公开交易供应商）的公司会计董事兼助理公司总会计师。职业生涯早期，他曾担任Ernst & Young公司的多种审计实践职务，并不断被提拔，也是注册会计师。
- Michael J. Bourque is our Senior Vice President, Chief Financial Officer and Treasurer, and has served in this capacity since July 13 2017. Mr. Bourque joined us in October 2014 as Vice President and Corporate Controller. He served as the Company’s interim Chief Financial Officer from April 2015 through November 2015 before being named principal accounting officer in December 2017. From July 2011 to October 2014 Mr. Bourque served as Vice President and Corporate Controller of Axcelis Technologies, Inc. which we refer to as Axcelis, a publicly traded supplier of products for the semiconductor manufacturing industry worldwide. He served as a financial consultant to Axcelis from April 2011 to July 2011. From November 2002 through October 2010 he served in a variety of finance and accounting roles, including Director of Corporate Accounting and Assistant Corporate Controller, at Charles River Laboratories, Inc., a publicly traded provider of products and services to leading pharmaceutical, biotechnology, government and academic organizations around the world. Earlier in his career, Mr. Bourque held various positions of increasing responsibility in the audit practice at Ernst & Young, LLP and is a certified public accountant.
- Brooks West
Brooks West于2017年3月加入我们，担任我们的高级副总裁兼全球超声波总经理。从2011年4月到2017年3月，他曾担任Piper Jaffrey公司（领先的投资银行和资产管理公司，主要负责心血管和多元化医疗技术领域）的高级研究分析师。加入Piper公司之前，West先生曾担任Urologix公司（泌尿外科市场医疗设备的供应商）的营销和业务发展领导职务。
Brooks West joined us as our Senior Vice President and General Manager, Global Ultrasound in March 2017. From April 2011 until March 2017 he served as a Senior Research Analyst for Piper Jaffrey, a leading investment bank and asset management firm with lead coverage of the cardiovascular and diversified medical technology sectors. Prior to joining Piper, Mr. West held leadership roles in marketing and business development at Urologix, a provider of medical devices for the urology market.- Brooks West于2017年3月加入我们，担任我们的高级副总裁兼全球超声波总经理。从2011年4月到2017年3月，他曾担任Piper Jaffrey公司（领先的投资银行和资产管理公司，主要负责心血管和多元化医疗技术领域）的高级研究分析师。加入Piper公司之前，West先生曾担任Urologix公司（泌尿外科市场医疗设备的供应商）的营销和业务发展领导职务。
- Brooks West joined us as our Senior Vice President and General Manager, Global Ultrasound in March 2017. From April 2011 until March 2017 he served as a Senior Research Analyst for Piper Jaffrey, a leading investment bank and asset management firm with lead coverage of the cardiovascular and diversified medical technology sectors. Prior to joining Piper, Mr. West held leadership roles in marketing and business development at Urologix, a provider of medical devices for the urology market.
- Fred B. Parks
Fred B. Parks，他担任NDS外科成像公司（先进的医疗可视化技术提供商）的行政总裁及董事从2011年至2013。他曾担任Urologix的董事会主席及行政总裁从2003至2008年。在加入Urologix前，他担任马可尼医疗系统（医疗成像设备的多模态供应商）的总裁兼首席执行官，后来该公司被皇家飞利浦电子收购，使其融入飞利浦医疗业务。此前，他担任圣犹达医疗用品公司（一家医疗设备公司，专注于植入式心血管产品）的总裁，首席营运官及董事会成员，并担任EG＆G公司（现在为珀金埃尔默，一家多元化的科技公司）总裁，首席营运官及董事会成员。除了他过去服务于NDS，Urologix，EG＆G，和圣犹达医疗的董事会，他还服务于稳态成像有限责任公司（一家私人持有的磁共振成像技术开发商）的董事会从2010年到2011。他的资历包括他的丰富工作经验，为一些科技公司的高级管理人员和董事会成员，特别是在医疗设备和医疗成像等行业。
Fred B. Parks has been our President and Chief Executive Officer since October 31 2016. Dr. Parks was the Executive Chairman and Chief Executive Officer of Enovate Medical, from 2015 to October 2016. Dr. Parks served as Chief Executive Officer and Director of NDS Surgical Imaging, Inc., a provider of advanced medical visualization technology, from 2011 to 2013 and was Chairman of the Board and Chief Executive Officer of Urologix, Inc. from 2003 to 2008. Prior to joining Urologix, Dr. Parks served as President and Chief Executive Officer of Marconi Medical Systems, a multi-modality supplier of medical imaging equipment, and following its acquisition by Royal Philips Electronics, led its integration into the Philips medical business. Previously, Dr. Parks held positions as President, Chief Operating Officer, and board member of St. Jude Medical, Inc., a medical device company focusing on implantable cardiovascular products, and as President, Chief Operating Officer, and board member of EG&G, Inc. now PerkinElmer, a diversified technology company.Dr. Parks became a Director of NuVectra Corporation, which is focused on the development and commercialization of neurostimulation technology, in March 2016. In addition to his past service on the boards of NDS, Urologix, EG&G, and St. Jude Medical, Dr. Parks served on the board of Steady State Imaging, LLC, a privately held developer of specialized magnetic resonance imaging technology, from 2010 to 2011.Dr. Parks’ qualifications include his substantial experience as a senior executive and board member for a number of technology companies, and particularly in the medical device and medical imaging industries. As President and Chief Executive Officer of Analogic, his in-depth knowledge of our Company provides our board with additional insight in areas such as strategic planning, financial and budgeting matters, engineering and product development, operations, sales and marketing, general management and other areas impacting our Company and its operations.- Fred B. Parks，他担任NDS外科成像公司（先进的医疗可视化技术提供商）的行政总裁及董事从2011年至2013。他曾担任Urologix的董事会主席及行政总裁从2003至2008年。在加入Urologix前，他担任马可尼医疗系统（医疗成像设备的多模态供应商）的总裁兼首席执行官，后来该公司被皇家飞利浦电子收购，使其融入飞利浦医疗业务。此前，他担任圣犹达医疗用品公司（一家医疗设备公司，专注于植入式心血管产品）的总裁，首席营运官及董事会成员，并担任EG＆G公司（现在为珀金埃尔默，一家多元化的科技公司）总裁，首席营运官及董事会成员。除了他过去服务于NDS，Urologix，EG＆G，和圣犹达医疗的董事会，他还服务于稳态成像有限责任公司（一家私人持有的磁共振成像技术开发商）的董事会从2010年到2011。他的资历包括他的丰富工作经验，为一些科技公司的高级管理人员和董事会成员，特别是在医疗设备和医疗成像等行业。
- Fred B. Parks has been our President and Chief Executive Officer since October 31 2016. Dr. Parks was the Executive Chairman and Chief Executive Officer of Enovate Medical, from 2015 to October 2016. Dr. Parks served as Chief Executive Officer and Director of NDS Surgical Imaging, Inc., a provider of advanced medical visualization technology, from 2011 to 2013 and was Chairman of the Board and Chief Executive Officer of Urologix, Inc. from 2003 to 2008. Prior to joining Urologix, Dr. Parks served as President and Chief Executive Officer of Marconi Medical Systems, a multi-modality supplier of medical imaging equipment, and following its acquisition by Royal Philips Electronics, led its integration into the Philips medical business. Previously, Dr. Parks held positions as President, Chief Operating Officer, and board member of St. Jude Medical, Inc., a medical device company focusing on implantable cardiovascular products, and as President, Chief Operating Officer, and board member of EG&G, Inc. now PerkinElmer, a diversified technology company.Dr. Parks became a Director of NuVectra Corporation, which is focused on the development and commercialization of neurostimulation technology, in March 2016. In addition to his past service on the boards of NDS, Urologix, EG&G, and St. Jude Medical, Dr. Parks served on the board of Steady State Imaging, LLC, a privately held developer of specialized magnetic resonance imaging technology, from 2010 to 2011.Dr. Parks’ qualifications include his substantial experience as a senior executive and board member for a number of technology companies, and particularly in the medical device and medical imaging industries. As President and Chief Executive Officer of Analogic, his in-depth knowledge of our Company provides our board with additional insight in areas such as strategic planning, financial and budgeting matters, engineering and product development, operations, sales and marketing, general management and other areas impacting our Company and its operations.
- John J. Fry
John J. Fry，他是公司的高级副总裁，总法律顾问兼秘书。他加入了公司于2007年11月。从2005年4月直到加入公司，他是德里格斯，霍格和弗莱有限公司的律师事务所（之前为德里格斯，卢卡斯，布鲁贝克和霍格有限公司）的负责人，在那里他的实践主要集中在技术和知识产权法。从1995年8月至2005年4月他曾在飞利浦医疗系统（原马可尼医疗系统和选择器国际）担任多个法律职务，包括高级企业法律顾问，知识产权经理和飞利浦的计算机断层扫描业务的法律顾问。
John J. Fry is our Senior Vice President, General Counsel, and Secretary. He joined us in November 2007. From April 2005 until joining us, Mr. Fry was a principal of the law firm Driggs, Hogg, & Fry Co., L.P.A., where his practice focused primarily on technology and intellectual property law. From August 1995 to April 2005 he held various legal positions at Philips Medical Systems, including Senior Corporate Counsel and Intellectual Property Manager and counsel to Philips’ computed tomography business.- John J. Fry，他是公司的高级副总裁，总法律顾问兼秘书。他加入了公司于2007年11月。从2005年4月直到加入公司，他是德里格斯，霍格和弗莱有限公司的律师事务所（之前为德里格斯，卢卡斯，布鲁贝克和霍格有限公司）的负责人，在那里他的实践主要集中在技术和知识产权法。从1995年8月至2005年4月他曾在飞利浦医疗系统（原马可尼医疗系统和选择器国际）担任多个法律职务，包括高级企业法律顾问，知识产权经理和飞利浦的计算机断层扫描业务的法律顾问。
- John J. Fry is our Senior Vice President, General Counsel, and Secretary. He joined us in November 2007. From April 2005 until joining us, Mr. Fry was a principal of the law firm Driggs, Hogg, & Fry Co., L.P.A., where his practice focused primarily on technology and intellectual property law. From August 1995 to April 2005 he held various legal positions at Philips Medical Systems, including Senior Corporate Counsel and Intellectual Property Manager and counsel to Philips’ computed tomography business.
- James P. Ryan
James P. Ryan，是我们的高级副总裁兼总经理，负责精密子系统和全球业务。他于2008年12月加入我们。2000年至加入我们，他曾担任Booz & Company（一个领先的全球管理咨询公司）的医疗保健和消费行业的战略实践负责人。任职Booz & Company之前，他曾任职Ingersoll-Rand公司，担任高级工程和制造职务。
James P. Ryan,is our Senior Vice President and General Manager, Precision Subsystems and Global Operations. Mr. Ryan joined us in December 2008. From 2000 until joining us, Mr. Ryan was a Principal in the Strategy Practice, focusing in the Healthcare and Consumer industries, for Booz & Company, a leading global management consulting firm. Prior to Booz & Company, he worked for Ingersoll-Rand in both advanced engineering and manufacturing capacities.- James P. Ryan，是我们的高级副总裁兼总经理，负责精密子系统和全球业务。他于2008年12月加入我们。2000年至加入我们，他曾担任Booz & Company（一个领先的全球管理咨询公司）的医疗保健和消费行业的战略实践负责人。任职Booz & Company之前，他曾任职Ingersoll-Rand公司，担任高级工程和制造职务。
- James P. Ryan,is our Senior Vice President and General Manager, Precision Subsystems and Global Operations. Mr. Ryan joined us in December 2008. From 2000 until joining us, Mr. Ryan was a Principal in the Strategy Practice, focusing in the Healthcare and Consumer industries, for Booz & Company, a leading global management consulting firm. Prior to Booz & Company, he worked for Ingersoll-Rand in both advanced engineering and manufacturing capacities.
- Mervat Faltas
Mervat Faltas，女，自2010年5月起她担任医学影像业务的高级副总裁和总经理。她于2005年7月加入Analogic的加拿大子公司（前身为Anrad），2006年1月担任营运副总裁，并被任命为Analogic公司加拿大子公司的总裁。从2000年5月至2005年6月她曾在ITF光学技术（光纤组件的陆地和海底通信网络的一个蒙特利尔的提供商）担任多个职位，包括担任总裁兼首席执行官。从1990年至2000年她在珀金埃尔默公司担任各种职位，包括PerkinElmer的蒙特利尔运营总经理。
Mervat Faltas is our Senior Vice President and General Manager, Medical Imaging, and has served in this capacity since May 2010. She joined ANRAD Corporation, our Canadian subsidiary now known as Analogic Canada Corporation, in July 2005 as Vice President of Operations and was named President of ANRAD in January 2006. From May 2000 until June 2005 Mrs. Faltas served in various capacities at ITF Optical Technologies, a Montreal-based provider of fiber optic components for terrestrial and undersea communication networks, including as President and Chief Executive Officer. From 1990 to 2000 Mrs. Faltas held various positions at PerkinElmer Corporation, including General Manager of PerkinElmer’s Montreal operation.- Mervat Faltas，女，自2010年5月起她担任医学影像业务的高级副总裁和总经理。她于2005年7月加入Analogic的加拿大子公司（前身为Anrad），2006年1月担任营运副总裁，并被任命为Analogic公司加拿大子公司的总裁。从2000年5月至2005年6月她曾在ITF光学技术（光纤组件的陆地和海底通信网络的一个蒙特利尔的提供商）担任多个职位，包括担任总裁兼首席执行官。从1990年至2000年她在珀金埃尔默公司担任各种职位，包括PerkinElmer的蒙特利尔运营总经理。
- Mervat Faltas is our Senior Vice President and General Manager, Medical Imaging, and has served in this capacity since May 2010. She joined ANRAD Corporation, our Canadian subsidiary now known as Analogic Canada Corporation, in July 2005 as Vice President of Operations and was named President of ANRAD in January 2006. From May 2000 until June 2005 Mrs. Faltas served in various capacities at ITF Optical Technologies, a Montreal-based provider of fiber optic components for terrestrial and undersea communication networks, including as President and Chief Executive Officer. From 1990 to 2000 Mrs. Faltas held various positions at PerkinElmer Corporation, including General Manager of PerkinElmer’s Montreal operation.